PDGFR-A is a Therapeutic Target in Alveolar Rhabdomyosarcoma

Alveolar rhabdomyosarcoma is an aggressive skeletal muscle cancer of childhood. Our initial studies of rhabdomyosarcoma gene expression for patients enrolled in a national clinical trial suggested that Platelet-derived Growth Factor Receptor A (PDGFR-A) may be a mediator of disease progression and m...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Taniguchi, E, Nishijo, K, McCleish, A T, Michalek, J E, Grayson, M H, Infante, A J, Abboud, H E, Legallo, R D, Qualman, S J, Rubin, B P, Keller, C
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2813858/
https://ncbi.nlm.nih.gov/pubmed/18679424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2008.255
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items